NCT03733093View on ClinicalTrials.gov

PREVAIL VIII: A CoHOrt Clinical, Viral, and ImmuNOlogic Monitoring Study of People Living With Retroviral Infection in Liberia (HONOR)

Active, not recruitingOBSERVATIONAL

Enrollment

1,377

Participants

Timeline

Start Date

August 22, 2019

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

HIV

Trial Locations (4)

Unknown

C.H. Rennie Hospital, Kakata

John F. Kennedy (JFK) Medical Center, Monrovia

Redemption Hospital, Monrovia

Duport Road Clinic, Paynesville

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT03733093 - PREVAIL VIII: A CoHOrt Clinical, Viral, and ImmuNOlogic Monitoring Study of People Living With Retroviral Infection in Liberia (HONOR) | Biotech Hunter | Biotech Hunter